Anxiety Disorder Treatment
Evidence-based therapy and medication for generalized anxiety, panic disorder, social anxiety, phobias, and agoraphobia — at every level of care.
Key Takeaways
- The five main DSM-5 anxiety disorders are Generalized Anxiety Disorder (GAD), Panic Disorder, Social Anxiety Disorder, Specific Phobia, and Agoraphobia.
- Cognitive Behavioral Therapy (CBT) with exposure components has the strongest evidence base — recovery rates of 50–75% across most anxiety disorders.
- SSRIs and SNRIs are first-line medications. Benzodiazepines are second-line because of dependence risk.
- Anxiety disorders frequently co-occur with depression (60% comorbidity) and substance use disorder (30%+) — integrated treatment is often necessary.
- Intensive outpatient and residential care become appropriate when daily function has collapsed or when exposure work needs structured support.
Anxiety disorders are the most common mental illnesses in the United States, affecting roughly 40 million adults each year. They are also among the most treatable — most people who complete an evidence-based course of treatment experience significant, lasting improvement.
This page covers the major anxiety disorders, the therapies and medications with the strongest evidence, and when an intensive program may be appropriate. Our admissions team can match you to a licensed provider at any level of care at no cost.
The Five Anxiety Disorders
Generalized Anxiety Disorder (GAD) — persistent, excessive worry across multiple life domains lasting six months or longer, accompanied by physical symptoms (muscle tension, fatigue, sleep disturbance, difficulty concentrating).
Panic Disorder — recurrent unexpected panic attacks plus persistent worry about future attacks or avoidance behavior. Panic attacks involve intense physical symptoms (racing heart, shortness of breath, dizziness) peaking within minutes.
Social Anxiety Disorder — intense fear of social or performance situations driven by fear of negative evaluation. Often leads to avoidance of work, school, or social functions.
Specific Phobia — marked fear of a specific object or situation (heights, flying, blood, animals) leading to avoidance disproportionate to the actual threat.
Agoraphobia — fear and avoidance of situations where escape or help might be difficult. Often, but not always, co-occurs with panic disorder.
First-Line Treatments
Cognitive Behavioral Therapy (CBT) with exposure components is the most evidence-supported treatment across every anxiety disorder. Exposure-based protocols gradually expose you to the feared stimulus or situation while preventing avoidance behaviors, allowing anxiety to extinguish naturally.
Acceptance and Commitment Therapy (ACT) targets the relationship with anxious thoughts rather than the thoughts themselves and shows comparable outcomes for GAD.
SSRIs and SNRIs are first-line medications — escitalopram, sertraline, paroxetine, venlafaxine, duloxetine. Onset of benefit takes 4–8 weeks; long-term combination of medication plus CBT outperforms either alone for many people.
Benzodiazepines (clonazepam, alprazolam, lorazepam) are highly effective short-term but carry physical dependence risk with prolonged use. They are typically reserved for crisis use or short bridges while SSRIs take effect.
Higher Levels of Care
Most anxiety disorders respond to weekly outpatient CBT and medication management. Intensive outpatient (IOP, 3 days/week) becomes appropriate when daily function has collapsed, when exposure work needs concentrated support, or when anxiety co-occurs with depression or substance use. Residential care is appropriate for severe agoraphobia, panic disorder, or OCD where intensive multi-hour daily exposure is needed — or when co-occurring substance use is destabilizing treatment.
Anxiety and Substance Use
Roughly one in three people with an anxiety disorder also meets criteria for a substance use disorder in the same year — alcohol is the most common, followed by sedatives and cannabis. Self-medication of anxiety is one of the most common pathways into addiction. Integrated dual diagnosis programs treat both simultaneously. See our Dual Diagnosis page for details.
Insurance Coverage
Under federal Mental Health Parity law, most plans must cover anxiety treatment at the same level as physical health care. Outpatient CBT and medication management are almost always covered. IOP, PHP, and residential require pre-authorization but are covered when medically necessary. We verify benefits at no cost.
Frequently Asked Questions
Is CBT really more effective than medication for anxiety?
For most anxiety disorders, CBT with exposure components is at least as effective as medication, and the benefits last longer after treatment ends. For moderate-to-severe anxiety, combining CBT with an SSRI or SNRI typically outperforms either alone.
Are benzodiazepines safe?
Benzodiazepines work fast and are very effective for acute anxiety, but they carry meaningful physical dependence risk with long-term daily use. Most evidence-based protocols use them only short-term — either for crisis or as a bridge while an SSRI takes effect.
How long does it take for an SSRI to work for anxiety?
Most people notice some benefit within 2–4 weeks and full effect at 6–8 weeks. Side effects (often mild) usually appear first and fade. If a first SSRI doesn’t work, a different SSRI or an SNRI is often tried before moving on to other classes.
When is residential treatment necessary for anxiety?
Residential care makes sense when daily function has collapsed, when severe agoraphobia or panic prevents outpatient attendance, when intensive exposure work needs structured daily support, or when co-occurring substance use is destabilizing outpatient treatment.
Free, confidential phone assessment — same day.
A licensed admissions counselor will verify your insurance benefits, talk through what’s going on, and help match you to the right level of care. No cost, no commitment.